O
Obaid S. Shaikh
Researcher at University of Pittsburgh
Publications - 63
Citations - 2411
Obaid S. Shaikh is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Liver transplantation & Hepatitis C. The author has an hindex of 22, co-authored 55 publications receiving 1766 citations. Previous affiliations of Obaid S. Shaikh include Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Outcomes in adults with acute liver failure between 1998 and 2013: An observational cohort study
Adrian Reuben,Holly Tillman,Robert J. Fontana,Timothy Davern,Brendan M. McGuire,R. Todd Stravitz,Valerie Durkalski,Anne M. Larson,Iris Liou,Oren K. Fix,Michael L. Schilsky,Timothy M. McCashland,J. Eileen Hay,Natalie Murray,Obaid S. Shaikh,Daniel Ganger,Atif Zaman,Steven B. Han,Raymond T. Chung,Alastair D. Smith,Robert S. Brown,Jeffrey S. Crippin,M. Edwyn Harrison,David G. Koch,Santiago Munoz,K. Rajender Reddy,Lorenzo Rossaro,Raj Satyanarayana,Tarek Hassanein,A. James Hanje,Jody C. Olson,Ram Subramanian,Constantine J. Karvellas,Bilal Hameed,Averell H. Sherker,Patricia R. Robuck,William M. Lee +36 more
TL;DR: This large cohort study found that despite similar causes and severity of ALF among patients referred to specialty centers from 1998 to 2013, the proportion of patients listed for liver transplantation decreased and survival improved among those who did not receive a transplant as well asThose who did.
Journal ArticleDOI
Outcome After Liver Transplantation for NASH Cirrhosis
TL;DR: Patients undergoing LT from 1997 to 2008 at a single center analyzed patients undergoing LT to determine outcome and poor predictive factors after LT for NASH cirrhosis.
Journal ArticleDOI
Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1
Thomas D. Boyer,Arun J. Sanyal,Florence Wong,R. Todd Frederick,John R. Lake,Jacqueline G. O'Leary,Daniel Ganger,Khurram Jamil,Stephen Chris Pappas,Samuel H. Sigal,Santiago J. Munoz,Vishal C. Patel,Paul Y. Kwo,Jasmohan S. Bajaj,Tarek Hassanein,Kirti Shetty,Rohit Satoskar,K. Rajender Reddy,Marlyn J. Mayo,Victor Araya,Nikroo Hashemi,Eyob Feyssa,Lorenzo Rossaro,David Kravetz,Priya Grewal,Ram Subramanian,Kevin M. Korenblat,Yuri Genyk,Fredric Regenstein,Joseph F. Buell,Nathan J. Shores,Sukru Emre,Andrea Duchini,Atif Zaman,Marco Olivera-Martinez,Michael K. Porayko,Alex S. Befeler,K. Gautham Reddy,Maria Del Pilar Hernandez,Stephen D. Zucker,Hugo E. Vargas,Michael P. Curry,Adnan Said,Kris V. Kowdley,Terry Box,David S. Barnes,Marie Noëlle Pépin,Madhavi Rudraraju,Paul Angulo,Howard Paul Monsour,David S. Wolf,Charles D. Howell,Fredric G. Regenstein,Antonio Sanchez,Hany Elbeshbeshy,Michael B. Fallon,Colin Swales,David A. Sass,Eva Urtasun Sotil,Brendan M. McGuire,Richard Gilroy,Juan A. Guerrero,Mark N. Wong,Obaid S. Shaikh,Stevan A. Gonzalez,Zeid Kayali +65 more
TL;DR: Terlipressin plus albumin was associated with greater improvement in renal function vs albumin alone in patients with cirrhosis and HRS-1, and overall survival was similar between groups.
Journal ArticleDOI
The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study.
Darrick K. Li,Yanjie Ren,Daniel S. Fierer,Stephanie M. Rutledge,Obaid S. Shaikh,Vincent Lo Re,Tracey G. Simon,Abdul-Badi Abou-Samra,Abdul-Badi Abou-Samra,Raymond T. Chung,Adeel A. Butt,Adeel A. Butt +11 more
TL;DR: DAA treatment is not associated with a higher risk of HCC in persons with cirrhosis with chronic HCV infection in the short term, according to a retrospective, population‐based cohort study using the ERCHIVES database.
Journal ArticleDOI
Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis
Shahid M. Malik,Michael E. DeVera,Paulo Fontes,Obaid S. Shaikh,Eizaburo Sasatomi,Jawad Ahmad +5 more
TL;DR: Recurrent fatty liver disease is common following liver transplantation for nonalcoholic steatohepatitis cirrhosis but does not lead to early allograft failure.